- FULC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
Fulcrum Therapeutics (FULC) S-1/AIPO registration (amended)
Filed: 8 Jul 19, 6:04am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated May 1, 2019 (except for Note 14(c), as to which the date is July 8, 2019), in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-232260) and related Prospectus of Fulcrum Therapeutics, Inc. dated July 8, 2019.
/s/ Ernst & Young LLP
Boston, Massachusetts
July 8, 2019
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.